Intracranial Atherosclerotic Burden on 7T MRI Is Associated with Markers of Extracranial Atherosclerosis: The SMART-MR Study

References

1. 1.↵
   1. Qureshi AI,
   2. Caplan LR.

   Intracranial atherosclerosis. Lancet 2014;383:984–98 doi:10.1016/S0140-6736(13)61088-0 pmid:24007975

   CrossRefPubMed
2. 2.↵
   1. Dearborn JL,
   2. Zhang Y,
   3. Qiao Y, et al

   . Intracranial atherosclerosis and dementia. Neurology 2017;88:1556–63 doi:10.1212/WNL.0000000000003837 pmid:28330958

   Abstract/FREE Full Text
3. 3.↵
   1. Gorelick P,
   2. Wong KS,
   3. Liu L.

   Epidemiology. Front Neurol Neurosci 2016;40:34–46 doi:10.1159/000448272 pmid:27960190

   CrossRefPubMed
4. 4.↵
   1. Qiao Y,
   2. Suri FK,
   3. Zhang Y, et al

   . Racial differences in prevalence and risk for intracranial atherosclerosis in a US community-based population. JAMA Cardiol 2017;2:1341–48 doi:10.1001/jamacardio.2017.4041 pmid:29094154

   CrossRefPubMed
5. 5.↵
   1. Sternby NH.

   Atherosclerosis in a defined population: an autopsy survey in Malmö, Sweden. Acta Pathol Microbiol Scand 1968:Suppl 194:5+ pmid:5668159

   PubMed
6. 6.↵
   1. D'Armiento FP,
   2. Bianchi A,
   3. de Nigris F, et al

   . Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001;32:2472–79 doi:10.1161/hs1101.098520 pmid:11692003

   Abstract/FREE Full Text
7. 7.↵
   1. Kiechl S,
   2. Willeit J

   . The natural course of atherosclerosis, Part I: incidence and progression. Arter Thromb Vasc Biol 1999;19:1484–90 doi:10.1161/01.atv.19.6.1484 pmid:10364079

   Abstract/FREE Full Text
8. 8.↵
   1. Ritz K,
   2. Denswil NP,
   3. Stam O, et al

   . Cause and mechanisms of intracranial atherosclerosis. Circulation 2014;130:1407–14 doi:10.1161/CIRCULATIONAHA.114.011147 pmid:25311618

   FREE Full Text
9. 9.↵
   1. Suri MF,
   2. Qiao Y,
   3. Ma X, et al

   . Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population: the Atherosclerosis Risk in Communities study. Stroke 2016;47:1187–93 doi:10.1161/STROKEAHA.115.011292 pmid:27056984

   Abstract/FREE Full Text
10. 10.↵
    1. López-Cancio E,
    2. Dorado L,
    3. Millán M, et al

    . The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: prevalence and risk factors. Atherosclerosis 2012;221:221–25 doi:10.1016/j.atherosclerosis.2011.12.020 pmid:22245037

    CrossRefPubMed
11. 11.↵
    1. Qiao Y,
    2. Anwar Z,
    3. Intrapiromkul J, et al

    . Patterns and implications of intracranial arterial remodeling in stroke patients. Stroke 2016;47:434–40 doi:10.1161/STROKEAHA.115.009955 pmid:26742795

    Abstract/FREE Full Text
12. 12.↵
    1. Zwartbol MHT,
    2. van der Kolk AG,
    3. Ghaznawi R, et al

    . Intracranial vessel wall lesions on 7T MRI. Stroke 2019;50:88–94 doi:10.1161/STROKEAHA.118.022509 pmid:30582831

    CrossRefPubMed
13. 13.↵
    1. Bhogal P,
    2. Navaei E,
    3. Makalanda HL, et al

    . Intracranial vessel wall MRI. Clin Radiol 2016;71:293–303 doi:10.1016/j.crad.2015.11.012 pmid:26711874

    CrossRefPubMed
14. 14.↵
    1. Harteveld AA,
    2. van der Kolk AG,
    3. van der Worp HB, et al

    . High-resolution intracranial vessel wall MRI in an elderly asymptomatic population: comparison of 3T and 7T. Eur Radiol 2017;27:1585–95 doi:10.1007/s00330-016-4483-3 pmid:27387876

    CrossRefPubMed
15. 15.↵
    1. Geerlings MI,
    2. Appelman AP,
    3. Vincken KL, et al

    . Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease: the SMART-MR study. Atherosclerosis 2010;210:130–36 doi:10.1016/j.atherosclerosis.2009.10.039 pmid:19945704

    CrossRefPubMed
16. 16.↵
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421 pmid:12485966

    FREE Full Text
17. 17.↵
    1. Simons PC,
    2. Algra A,
    3. Van De Laak MF, et al

    . Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15:773–81 doi:10.1023/A:1007621514757 pmid:10608355

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Winter MA,
    2. Guhr KN,
    3. Berg GM.

    Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault Equation. Pharmacother J Hum Pharmacol Drug Ther 2012;32:604–12 doi:10.1002/j.1875-9114.2012.01098.x pmid:22576791

    CrossRefPubMed
19. 19.↵
    1. van der Kolk AG,
    2. Hendrikse J,
    3. Brundel M, et al

    . Multi-sequence whole-brain intracranial vessel wall imaging at 7.0 Tesla. Eur Radiol 2013;23:2996–3004 doi:10.1007/s00330-013-2905-z pmid:23736375

    CrossRefPubMed
20. 20.↵
    1. van der Kolk AG,
    2. Zwanenburg JJ,
    3. Brundel M, et al

    . Distribution and natural course of intracranial vessel wall lesions in patients with ischemic stroke or TIA at 7.0 Tesla MRI. Eur Radiol 2015;25:1692–700 doi:10.1007/s00330-014-3564-4 pmid:25577517

    CrossRefPubMed
21. 21.↵
    1. Lindenholz A,
    2. van der Kolk AG,
    3. Zwanenburg JJ, et al

    . The use and pitfalls of intracranial vessel wall imaging: how we do it. Radiology 2018;286:12–28 doi:10.1148/radiol.2017162096 pmid:29261469

    CrossRefPubMed
22. 22.↵
    1. Holmstedt CA,
    2. Turan TN,
    3. Chimowitz MI.

    Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol 2013;12:1106–14 doi:10.1016/S1474-4422(13)70195-9 pmid:24135208

    CrossRefPubMed
23. 23.↵
    1. Aboyans V,
    2. Criqui MH,
    3. Abraham P, et al

    . Measurement and interpretation of the Ankle-Brachial Index: a scientific statement from the American Heart Association. Circulation 2012;126:2890–909 doi:10.1161/CIR.0b013e318276fbcb pmid:23159553

    FREE Full Text
24. 24.↵
    1. López-Cancio E,
    2. Galán A,
    3. Dorado L, et al

    . Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study. Stroke 2012;43:2712–19 doi:10.1161/STROKEAHA.112.661702 pmid:22798326

    Abstract/FREE Full Text
25. 25.↵
    1. Odink AE,
    2. van der Lugt A,
    3. Hofman A, et al

    . Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam study. Atherosclerosis 2007;193:408–13 doi:10.1016/j.atherosclerosis.2006.07.007 pmid:16919637

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Mandell DM,
    2. Mossa-Basha M,
    3. Qiao Y, et al

    . Intracranial Vessel Wall MRI: Principles and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol 2017;38:218–29 doi:10.3174/ajnr.A4893 pmid:27469212

    Abstract/FREE Full Text
27. 27.↵
    1. Resch JA,
    2. Baker AB.

    Etiologic mechanisms in cerebral atherosclerosis: preliminary study of 3,839 cases. Arch Neurol 1964;10:617–28 doi:10.1001/archneur.1964.00460180083008 pmid:14130420

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Mathur KS,
    2. Kashyap SK,
    3. Kumar V.

    Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963;27:929–34 doi:10.1161/01.cir.27.5.929 pmid:13933662

    Abstract/FREE Full Text
29. 29.↵
    1. Bots ML,
    2. Sutton-Tyrrell K.

    Lessons from the past and promises for the future for carotid intima-media thickness. J Am Coll Cardiol 2012;60:1599–604 doi:10.1016/j.jacc.2011.12.061 pmid:22999720

    FREE Full Text
30. 30.↵
    1. Iwakiri T,
    2. Yano Y,
    3. Sato Y, et al

    . Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: findings from autopsy analysis. Atherosclerosis 2012;225:359–62 doi:10.1016/j.atherosclerosis.2012.10.033 pmid:23092826

    CrossRefPubMed
31. 31.↵
    1. Mizukami H,
    2. Shimizu T,
    3. Maki F, et al

    . Progression of intracranial major artery stenosis is associated with baseline carotid and intracranial atherosclerosis. J Atheroscler Thromb 2015;22:183–90 doi:10.5551/jat.26054 pmid:25195812

    CrossRefPubMed
32. 32.↵
    1. Caplan LR,
    2. Gorelick PB,
    3. Hier DB.

    Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986;17:648–55 doi:10.1161/01.str.17.4.648 pmid:3526645

    FREE Full Text
33. 33.↵
    1. Bos D,
    2. van der Rijk MJ,
    3. Geeraedts TE, et al

    . Intracranial carotid artery atherosclerosis: prevalence and risk factors in the general population. Stroke 2012;43:1878–84 doi:10.1161/STROKEAHA.111.648667 pmid:22569939

    Abstract/FREE Full Text
34. 34.↵
    1. Bos D,
    2. Portegies ML,
    3. van der Lugt A, et al

    . Intracranial carotid artery atherosclerosis and the risk of stroke in whites. JAMA Neurol 2014;71:405 doi:10.1001/jamaneurol.2013.6223 pmid:24535643

    CrossRefPubMed
35. 35.↵
    1. Man BL,
    2. Fu YP.

    Concurrent stenoses: a common etiology of stroke in Asians. World J Clin Cases 2014;2:201–05 doi:10.12998/wjcc.v2.i6.201 pmid:24945006

    CrossRefPubMed
36. 36.↵
    1. Manzano JJ,
    2. De Silva DA,
    3. Pascual JL, et al

    . Associations of ankle-brachial index (ABI) with cerebral arterial disease and vascular events following ischemic stroke. Atherosclerosis 2012;223:219–22 doi:10.1016/j.atherosclerosis.2012.04.009 pmid:22652527

    CrossRefPubMed
37. 37.↵
    1. Nakano T,
    2. Ohkuma H,
    3. Suzuki S.

    Measurement of ankle brachial index for assessment of atherosclerosis in patients with stroke. Cerebrovasc Dis 2004;17:212–17 doi:10.1159/000075793 pmid:14707424

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Jiménez M,
    2. Dorado L,
    3. Hernández-Pérez M, et al

    . Ankle-brachial index in screening for asymptomatic carotid and intracranial atherosclerosis. Atherosclerosis 2014;233:72–75 doi:10.1016/j.atherosclerosis.2013.12.021 pmid:24529125

    CrossRefPubMed
39. 39.↵
    1. Manjunath G,
    2. Tighiouart H,
    3. Ibrahim H, et al

    . Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003;41:47–55 doi:10.1016/s0735-1097(02)02663-3 pmid:12570944

    FREE Full Text
40. 40.↵
    1. Makin SD,
    2. Cook FA,
    3. Dennis MS, et al

    . Cerebral small vessel disease and renal function: systematic review and meta-analysis. Cerebrovasc Dis 2015;39:39–52 doi:10.1159/000369777 pmid:25547195

    CrossRefPubMed
41. 41.↵
    1. Power A,
    2. Chan K,
    3. Haydar A, et al

    . Intracranial arterial calcification is highly prevalent in hemodialysis patients but does not associate with acute ischemic stroke. Hemodial Int 2011;15:256–63 doi:10.1111/j.1542-4758.2011.00543.x pmid:21410636

    CrossRefPubMed
42. 42.↵
    1. Qing HA,
    2. Gottesman R,
    3. Qiao Y, et al

    . Abstract TMP52: Association of chronic kidney disease and intracranial atherosclerotic disease by high resolution vessel wall MRI: the ARIC study. Stroke 2018;49(Suppl 1) doi:10.1161/str.49.suppl_1.TMP52

    CrossRef
43. 43.↵
    1. Harteveld AA,
    2. van der Kolk AG,
    3. van der Worp HB, et al

    . Detecting intracranial vessel wall lesions with 7T-magnetic resonance imaging: patients with posterior circulation ischemia versus healthy controls. Stroke 2017;48:2601–04 doi:10.1161/STROKEAHA.117.017868 pmid:28701579

    Abstract/FREE Full Text
44. 44.↵
    1. van Hespen KM,
    2. Zwanenburg JJ,
    3. Harteveld AA, et al

    . Intracranial vessel wall magnetic resonance imaging does not allow for accurate and precise wall thickness measurements. Stroke 2019;50:e283–84 doi:10.1161/STROKEAHA.119.026497

    CrossRef